• Funding Support

    We would like to thank everyone who has provided funding support for our research, including the following foundations and agencies.

  • R21 AI103853 (Zimmermann)
    NIH / NIAID
    "Molecular mechanism of eosinophil cell death"(Zimmermann)
    Role on grant: Principal Investigator (10% effort)
    Period: 07/01/13-06/30/15
    Annual direct cost: $150,000

    Contract with Allakos (SRA130701)
    “Testing of anti-Siglec-8 antibodies in NSGS mice and their effect on eosinophil levels” (Zimmermann)
    Role on grant: Principal Investigator (6% effort over entire project period)
    Period: 07/2013-Ongoing
    Total direct cost: $28,660

    P30 DKL078392 Digestive Health Center (Bezerra) 
    Cincinnati Children's Hospital Medical Center
    "Measurement of tissue pH in experimental eosinophilic esophagitis and food allergy" (Zimmermann)
    Role on center-awarded grant: Principal Investigator (10% effort)
    Period: 06/01/11-05/31/12
    Annual direct cost: $50,000

    AI-167552-N (Zimmermann) 
    Allergic Respiratory Diseases Award
    ALA/AAAAI
    “Mechanisms of airway acidification in asthma”
    Role on grant: Principal Investigator (15% effort)
    Period: 07/01/10 -06/30/12            
    Annual direct cost: $50,000

    AI088559-01 (Zimmermann) 
    NIH / NIAID 
    “Role for acidity and GPR65 in food allergy”
    Role on grant: Principal Investigator (30% effort)
    Period: 03/03/10-02/29/13        
    Annual direct cost: $125,000

    AI079251-01A1 (Zimmermann)
    NIH / NIAID
    “Role of acidic environment in eosinophilic inflammation”
    Role on grant: Principal Investigator (40% effort)
    Period: 04/01/09-03/31/11 
    Annual direct cost: $150,000

    President's Grant-in-Aid Award (Zimmermann)
    AAAAI
    “Identification and characterization of the CC chemokine receptor-3 promoter”
    Role on grant: Principal Investigator
    Period: 1999-2000
    Annual direct cost: $20,000

    Fellowship in Pulmonary Research (Zimmermann)
    Parker B. Francis
    "Modulation of CC chemokine receptor-3 expression and function"
    Role on grant: Principal Investigator
    Period: 07/01/99-06/30/02
    Annual direct cost: $40,000

    University Research Council Grant (Zimmermann)
    University of Cincinnati
    "Gene transfer into eosinophils using CCR-3-mediated internalization"
    Role on grant: Principal Investigator
    Period: 06/01/01-05/31/02

    Scientist Development Grant (Zimmermann)
    AHA (National)
    "Regulation of CC chemokine receptor 3 expression"
    Role on grant: Principal Investigator
    Period: 01/01/01-12/31/04
    Annual direct cost: $65,000

    Woman Physician in Allergy Junior Faculty Award (Zimmermann)
    AAAAI / Aventis
    “The role of TDAG8 in allergic airway inflammation”
    Role on grant: Principal Investigator
    Period: 2004-2005
    Annual direct cost: $20,000

    Trustee Grant (Zimmermann)
    Cincinnati Children’s Hospital Medical Center
    “The role of TDAG8 in allergic inflammation” 
    Role on grant: Principal Investigator
    Period: 07/01/04-06/30/06
    Annual direct cost: $50,000

    AMA Foundation Seed Grant (Fulkerson)
    Role on grant: Mentor
    Period: 07/01/06-06/30/07
    Award amount: $2,500

    R01 AI53479-01 (Rothenberg)
    NIH / NIAID
    “The role of arginase in allergic airway inflammation”
    Role on grant: Co-investigator (40% effort)
    Period: 11/01/02-10/31/07
    Annual direct cost: $250,000

    Translational Research Initiative Grant (Zimmermann)
    Cincinnati Children’s Hospital Medical Center
    “Targeting eosinophils by anti-Siglec treatment”
    Role on grant: Principal Investigator (15% effort)
    Period: 07/01/07-06/30/08
    Annual direct cost: $96,459

    Contract with Merck Co.
    “The role of GPR65 / TDAG8 in airway inflammation”
    Role on grant: Co-Principal Investigator (25% effort)
    Period: 2007-2008
    Annual direct cost: $100,000

    #6-FY06-1303 (Zimmermann)
    March of Dimes
    “The role of arginine transport in the development of inflammatory homeostasis in the lung”
    Role on grant: Principal Investigator (10% effort)
    Period: 06/01/06-05/30/09
    Annual direct cost: $80,995

    Dana Foundation (Bochner)
    “Novel genetic and therapeutic approaches focusing on Siglec-8 for the diagnosis and treatment of human idiopathic eosinophilic disorders”
    Role on grant: Co-investigator (25% effort)
    Period: 10/07-09/10
    Annual direct cost: $100,000

  • Contact Us

    For more information about the lab, contact Nives Zimmermann at nives.zimmermann@cchmc.org.
  • Digestive Health Center

    Zimmermann is an associate member of Cincinnati Children's Digestive Health Center (DHC), which is focused on bench-to-bedside research in pediatric digestive disease. A past funding award from the DHC supported her investigation of Siglec-8 as a potential target for eosinophilic inflammatory diseases.
  • Research Opportunities

    Zimmermann is the director of admissions for the MS track of the Immunobiology Graduate Training Program. She mentors graduate students and postdoctoral fellows in basic and translational research.